Department of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium.
Department of Nephrology-Dialysis-Apheresis, Hopital Universitaire Carémeau, Nîmes, France.
Br J Clin Pharmacol. 2022 May;88(5):2118-2127. doi: 10.1111/bcp.15132. Epub 2021 Dec 3.
The Cockcroft-Gault (CG) creatinine-based equation is still used to estimate glomerular filtration rate (eGFR) for drug dosage adjustment. Incorrect eGFR may lead to hazardous over- or underdosing.
In a cross-sectional analysis, CG was validated against measured GFR (mGFR) in 14 804 participants and compared with the Modification-of-Diet-in-Renal-Diseases (MDRD), Chronic-Kidney-Disease-Epidemiology (CKD-EPI), Lund-Malmö-Revised (LMR) and European-Kidney-Function-Consortium (EKFC) equations. Validation focused on bias, imprecision and accuracy (percentage of estimates within ±30% of mGFR, P30), overall and stratified for mGFR, age and body mass index at mGFR <60 mL/min, as well as classification in mGFR stages.
The CG equation performed worse than the other equations, overall and in mGFR, age and BMI subgroups in terms of bias (systematic overestimation), imprecision and accuracy except for patients ≥65 years where bias and P30 were similar to MDRD and CKD-EPI, but worse than LMR and EKFC. In subjects with mGFR <60 mL/min and at BMI 18.5-25 kg/m , all equations performed similarly, and for BMI < 18.5 kg/m CG and LMR had the best results though all equations had poor P30-accuracy. At BMI ≥ 25 kg/m the bias of the CG increased with increasing BMI (+17.2 mL/min at BMI ≥ 40 kg/m ). The four more recent equations also classified mGFR stages better than CG.
The CG equation showed poor ability to estimate GFR overall and in analyses stratified for mGFR, age and BMI. CG was inferior to correctly classify the patients in the mGFR staging compared to more recent creatinine-based equations.
科克罗夫特-高特(CG)基于肌酐的方程仍被用于估计肾小球滤过率(eGFR)以调整药物剂量。不正确的 eGFR 可能导致危险的剂量过高或过低。
在一项横断面分析中,CG 与 14804 名参与者的实测肾小球滤过率(mGFR)进行了验证,并与改良肾脏病饮食研究(MDRD)、慢性肾脏病流行病学合作研究(CKD-EPI)、隆德-马尔默修订版(LMR)和欧洲肾脏功能协作组(EKFC)方程进行了比较。验证侧重于偏倚、不精确性和准确性(估计值在 mGFR 的±30%范围内的百分比,P30),以及总体和按 mGFR、年龄和 mGFR<60mL/min 时的 BMI 分层,以及 mGFR 分期的分类。
CG 方程在总体上以及在 mGFR、年龄和 BMI 亚组中,与其他方程相比,在偏倚(系统高估)、不精确性和准确性方面表现不佳,除了≥65 岁的患者,其偏倚和 P30 与 MDRD 和 CKD-EPI 相似,但不如 LMR 和 EKFC。在 mGFR<60mL/min 且 BMI 为 18.5-25kg/m 的患者中,所有方程的表现都相似,而在 BMI<18.5kg/m 时,CG 和 LMR 的结果最好,尽管所有方程的 P30 准确性都很差。在 BMI≥25kg/m 时,CG 的偏倚随 BMI 的增加而增加(在 BMI≥40kg/m 时增加 17.2mL/min)。这四个更新的方程也能更好地对 mGFR 分期进行分类。
CG 方程在总体上以及按 mGFR、年龄和 BMI 分层的分析中,对 GFR 的估计能力较差。与基于肌酐的最新方程相比,CG 对患者在 mGFR 分期中的分类能力较差。